Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.51 Down 0.18(6.69%) 4:00PM EST
|After Hours : 2.51 0.00 (0.00%) 4:49PM EST
Prev Close:2.69
Open:2.69
Bid:N/A
Ask:2.85 x 800
1y Target Est:10.00
Beta:1.50918
Earnings Date:Mar 1 - Mar 7 (Est.)
Day's Range:2.50 - 2.69
52wk Range:2.28 - 5.20
Volume:447,850
Avg Vol (3m):551,231
Market Cap:222.20M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
RIGLDown 6.69%222.20M
AMGNDown 3.25%109.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.57
Quarterly EPS Est (Dec-15) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback